Author

Franca Formelli

Observed names: F FORMELLI, F Formelli, F. FORMELLI, F. Formelli, FRANCA FORMELLI

Institution: Fondazione IRCCS Istituto Nazionale dei Tumori

Observed institutions: University of Geneva, National Institutes of Health, University of Strathclyde, University of Milan, Istituto Giannina Gaslini, Biomedical Primate Research Centre, Ente Ospedaliero Ospedali Galliera, Ospedale San Paolo, Azienda Sanitaria Unità Locale di Reggio Emilia, Fondazione Michelangelo, National Cancer Institute, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Fondazione IRCCS Istituto Nazionale dei Tumori, McGill University, European Institute of Oncology, University of Milano-Bicocca, University of Genoa, University of Bologna

OpenAlex ID: A5035474342

Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells

2002 · Valentina Zuco, Rosanna Supino, et al. · Cancer Letters · 539

Randomized Trial of Fenretinide to Prevent Second Breast Malignancy in Women With Early Breast Cancer

1999 · U. Veronesi, G. De Palo, et al. · JNCI Journal of the National Cancer Institute · 412

In vitro and In vivo Activity of SKI-606, a Novel Src-Abl Inhibitor, against Imatinib-Resistant Bcr-Abl+ Neoplastic Cells

2006 · Miriam Puttini, Addolorata Maria Luce Coluccia, et al. · Cancer Research · 382

In Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase Inhibitor

1999 · Philipp le Coutre, Luca Mologni, et al. · JNCI Journal of the National Cancer Institute · 374

N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.

1993 · D Delia, A Aiello, et al. · PubMed · 242

Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer

2006 · U. Veronesi, L. Mariani, et al. · Annals of Oncology · 218

Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations.

1993 · F Formelli, M Clerici, et al. · Journal of Clinical Oncology · 195

Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone

1975 · Federico Arcamone, Sergio Penco, et al. · Journal of Medicinal Chemistry · 193

Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma.

2003 · Alberto Garaventa, Roberto Luksch, et al. · PubMed · 187

Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2

1995 · D Delia, A Aiello, et al. · Blood · 150

PDF

Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients.

1989 · F Formelli, R Carsana, et al. · PubMed · 138

Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity.

1993 · F Formelli, L Cleris · PubMed · 132

Tolerability of the synthetic retinoid fenretinide® (HPR)

1989 · Alberto Costa, Winfred Malone, et al. · European Journal of Cancer and Clinical Oncology · 124

Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression

1996 · Rosanna Supino, Mariacristina Crosti, et al. · International Journal of Cancer · 121

PDF

Can Fenretinide Protect Women Against Ovarian Cancer?

1995 · G. DE PALO, U. VERONESI, et al. · JNCI Journal of the National Cancer Institute · 116

PDF

Growth-inhibitory effect of STI571 on cells transformed by theCOL1A1/PDGFB rearrangement

2001 · A. Greco, E. Roccato, et al. · International Journal of Cancer · 115

PDF

Randomized Double-Blind 2 × 2 Trial of Low-Dose Tamoxifen and Fenretinide for Breast Cancer Prevention in High-Risk Premenopausal Women

2009 · Andrea Decensi, Chris Robertson, et al. · Journal of Clinical Oncology · 114

Bioactivities of N‐(4‐hydroxyphenyl) retinamide and retinoyl β‐glucuronide

1996 · Franca Formelli, Arun B. Barua, et al. · The FASEB Journal · 113

Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide.

1994 · A Costa, F Formelli, et al. · PubMed · 112

Long-term tolerability of fenretinide (4-HPR) in breast cancer patients

1991 · N. Rotmensz, G. De Palo, et al. · European Journal of Cancer and Clinical Oncology · 112

In vitro interaction of fenretinide with plasma retinol‐binding protein and its functional consequences

1992 · Rodolfo Berni, Franca Formelli · FEBS Letters · 107

PDF

Prevention of local relapses and new localisations of oral leukoplakias with the synthetic retinoid fenretinide (4-HPR). Preliminary results

1992 · F. Chiesa, N. Tradati, et al. · European Journal of Cancer Part B Oral Oncology · 102

Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the pml/RAR alpha protein

1993 · S Dermime, F Grignani, et al. · Blood · 100

PDF

Effect of Fenretinide on Ovarian Carcinoma Occurrence

2002 · Giuseppe De Palo, Luigi Mariani, et al. · Gynecologic Oncology · 96

Effect of Fenretinide and Low-Dose Tamoxifen on Insulin Sensitivity in Premenopausal Women at High Risk for Breast Cancer

2008 · Harriet Johansson, Sara Gandini, et al. · Cancer Research · 92

Works count: 166

Citation count: 7,565

H-index: 47

I10-index: 103